Form 4: Guardant Health Executive Darya Chudova Reports Stock Transactions
SEC Form 4 Filing
Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- Darya Chudova, Chief Technology Officer of Guardant Health, reported transactions involving the company's common stock on September 9, 2024.
- 2,909 restricted stock units vested, and 1,260 shares were withheld by the company to cover tax obligations.
- Following these transactions, Chudova directly owns 45,915 shares of Guardant Health common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard executive compensation practices, and doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they relate to executive compensation and do not represent a significant change in ownership.
Key Dates
| Date | Description |
|---|---|
| September 11, 2020 | Date the restricted stock unit award was granted. |
| May 3, 2023 | Date Darya Chudova was elected as an executive officer. |
| September 9, 2023 | First vesting date of the restricted stock units (25%). |
| September 9, 2024 | Date of the reported transactions: vesting of restricted stock units and tax withholding. |
| September 10, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.